Concepedia

Abbas Alalikhan

AA

Statistics

Publications

4

Citations

72

H-Index

4

Active since

2022

Affiliations

Mashhad University of Medical Sciences(Current)

Varastegan Institute for Medical Sciences

North Khorasan University of Medical Sciences

Abbas Alalikhan is an author at Mashhad University of Medical Sciences specializing in oncology, cancer pharmacology, and pharmacology.

Publications per year

2022–2023

4

Publications

4

RETRACTED ARTICLE: The effect of substance P and its specific antagonist (aprepitant) on the expression of MMP-2, MMP-9, VEGF, and VEGFR in ovarian cancer cells

Maryam Momen Razmgah, Atefeh Ghahremanloo, Hossein Javid et al. · Molecular Biology Reports · 2022 · 27 citations

Medicine, Oncology, Pharmacology +16

The Potential In Vitro Inhibitory Effects of Neurokinin‐1 Receptor (NK‐1R) Antagonist, Aprepitant, in Osteosarcoma Cell Migration and Metastasis

Mohammed Ali Alsaeed, Safieh Ebrahimi, Abbas Alalikhan et al. · BioMed Research International · 2022 · 20 citations · Full text

Medicine, Oncology, Pharmacology +11

The Effect of Blocking Neurokinin-1 Receptor by Aprepitant on the Inflammatory and Apoptosis Pathways in Human Ovarian Cancer Cells

Abbas Alalikhan, Atefeh Ghahremanloo, Hossein Javid et al. · Cell Biochemistry and Biophysics · 2022 · 13 citations

Life Sciences, Oncology, Pharmacology +14

The In Vitro Pro-inflammatory Functions of the SP/NK1R System in Prostate Cancer: a Focus on Nuclear Factor-Kappa B (NF-κB) and Its Pro-inflammatory Target Genes

Safieh Ebrahimi, Bahareh Erfani, Abbas Alalikhan et al. · Applied Biochemistry and Biotechnology · 2023 · 12 citations

Medicine, Immunology, Oncology +17

1–4 of 4